扩展受控温度条件下麻疹疫苗冷链外稳定性评估
本研究利用印度血清研究所有限公司提供的37°C和40°C稳定性数据,应用扩展受控温度条件(ECTC)产品放行模型,评估麻疹疫苗冷链外偏移的可能性。结果显示,冻干麻疹疫苗在37°C下至多6天、40°C下至多2天,在货架寿命末仍保持高于最低效价要求,支持单剂次麻疹疫苗在ECTC下使用。
要点
- 冻干麻疹疫苗在37°C下至多6天、40°C下至多2天仍保持高于最低效价要求。
- 该评估支持单剂次麻疹疫苗在扩展受控温度条件下使用。
- 该做法对偏远难以到达地区的疫情应对可能有利,但操作优势尚需确立。
核心结论
- 冻干麻疹疫苗在37°C下至多6天、40°C下至多2天,在货架寿命末仍保持高于最低效价要求,支持单剂次麻疹疫苗在ECTC下使用。
- 该做法对偏远难以到达地区的疫情应对可能有利,但该方法的操作优势尚需确立。
研究设计与样本
- 利用印度血清研究所有限公司提供的37°C和40°C稳定性数据,应用扩展受控温度条件(ECTC)产品放行模型进行评估。
主要发现
- 冻干麻疹疫苗在37°C下至多6天、40°C下至多2天,在货架寿命末仍保持高于最低效价要求。
- 该评估支持单剂次麻疹疫苗在ECTC下使用。
- 该做法对偏远难以到达地区的疫情应对可能有利。
关键数值与推荐
- 冻干麻疹疫苗在37°C下至多6天、40°C下至多2天,在货架寿命末仍保持高于最低效价要求。
临床怎么用
- 该评估支持单剂次麻疹疫苗在扩展受控温度条件下使用,该做法对偏远难以到达地区的疫情应对可能有利。
- 该方法的操作优势尚需确立。
局限性
- 该方法的操作优势尚需确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measles outbreaks occur periodically in remote and difficult to reach areas in countries such as the Democratic Republic of Congo. The possibility to keep measles vaccines at temperatures outside the cold chain for a limited period prior to administration would be an advantage for organizations such as Médecins Sans Frontières, which repeatedly respond to measles outbreaks in difficult contexts. Using stability data at 37 °C and 40 °C provided by Serum Institute of India Private Limited we applied the product release model for Extended Controlled Temperature Conditions (ECTC) to evaluate the possibility of an out of the cold chain excursion. Measles vaccine in the lyophilized form remains above the minimum required potency at the end of the shelf-life for up to 6 days at 37 °C or for 2 days at 40 °C. This evaluation supports the use of a monodose presentation of measles vaccine in ECTC. This could be an advantage for outbreak response in isolated and difficult to reach areas. However the operational advantages of this approach need to be established.
引用
- Juan-Giner A, Alsalhani A, Panunzi I, et al. Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions. Vaccine. 2020. PMID: 32046890. doi:10.1016/j.vaccine.2020.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。